The utility of blood cultures in the management of non-facial cellulitis appears to be low

New Zealand Medical Journal

Volumn 118, Issue 1211, 2005, Pages

  Stevenson, Anna ^a   Hider, Phil ^a   Than, Martin ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; BLOOD CULTURE; CASE STUDY; CELLULITIS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DATA BASE; DRUG COST; EMERGENCY WARD; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HUMAN; INFORMATION PROCESSING; NEEDLE BIOPSY; NEW ZEALAND; RELIABILITY; RETROSPECTIVE STUDY; SAFETY; SOFT TISSUE INFECTION; SYSTEMATIC REVIEW; VALIDATION PROCESS; ADULT; BACTEREMIA; BLOOD; ECONOMICS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; REVIEW;

ADULT; BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; BLOOD; CELLULITIS; HUMANS; RETROSPECTIVE STUDIES;

EID: 21244468376     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Weinbaum FIL, Danek S, Sixsmith M, et al. Doing it right the first time: quality improvement and the contaminant blood culture. J Clin Microbiol. 1997;35:563-5.
2. Craig JC, Irwig LM, Stockler MR. Evidence-based Medicine: Useful tools for decision making. Med J Aust. 2001;174:248-53.
3. Young J, Hyde C, Fry-Smith A, et al. Appendix IV. Validity assessment criteria. In: Lung volume reduction surgery (LVRS) for chronic obstructive pulmonary disease (COPD) with underlying severe emphysema. Report No. 15. Birmingham: West Midlands Development and Evaluation Committee; 1999, Appendix IV.
4. Oxford Centre for Evidence Based Medicine. Levels of Evidence. Available online. URL: http://www.cebm.net/levels_of_evidence.asp Accessed March 2005
5. Jorup-Ronstrom C. Epidemiological, bacteriological and complicating features of erysipelas. Scand J Infect Dis. 1986;18:519-24.
6. Goldgeier MH. The microbial evaluation of acute cellulitis. Cutis. 1983;31:649-50, 653-4, 656.
7. Kelly A. Rationalising the ordering of blood cultures. Aust Health Rev.. 1998;21:245-50.
8. Ho PW, Pien FD, Hamburg D. Value of cultures in patients with acute cellulitis. South Med J. 1979;72:1402-3.
9. Hook EW, 3rd, Hooton TM, Horton CA, et al. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med. 1986;146:295-7.
10. Liles DK, Dall LH. Needle aspiration for diagnosis of cellulitis. Cutis. 1985;36:63-4.
11. Perl B, Gottehrer NP, Raveh D, et al. Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis. 1999;29:1483-8.
12. Kelly A. Clinical impact of blood cultures taken in the emergency department. J Accid Emerg Med. 1998;15:254-6.
13. Stalnikowicz R, Block C. The yield of blood cultures in a department of emergency medicine. Eur J Emerg Med. 2001;8:93-7.
14. Aly AA, Roberts NM, Seipol KS, et al. Case survey of management of cellulitis in a tertiary teaching hospital.[comment]. Med J Aust. 1996;165:553-6.
15. Dong SL, Kelly KD, Oland RC, et al. ED Management of Cellulitis: A Review of Five Urban Centres. Am J Emerg Med. 2001;19:535.
16. Jones GR. A re-evaluation of blood cultures. Reviews in Medical Microbiology. 1995;6:109-18.
17. Mylotte JM, Tayara A. Blood cultures: Clinical aspects and controversies. Eur J Clin Microbiol Infect Dis. 2000;19:157-63.
18. Bates DW, Goldman L, Lee TH. Contaminant blood cultures and resource utilization: the true consequences of false-positive results. JAMA. 1991;265:365-9.
19. Surdulescu S, Utamsingh D, Shekar R. Phlebotomy teams reduce blood-culture contamination rate and save money. Clin Perform Qual Health Care. 1998;6:60-3.
20. Gibb AP, Hill B, Chorel B, et al. Reduction in blood culture contamination rate by feedback to phlebotomists. Arch Pathol Lab Med. 1997;121:503-7.
21. Jaimes F, Arango C, Ruiz G, et al. Predicting bacteraemia at the bedside. Clin Infect Dis. 2004;38:357-62.
22. Bates DW, Cook EF, Goldman L, et al. Predicting bacteremia in hospitalized patients: A prospectively validated model. Ann Intern Med. 1990;113:495-500.
23. Mozes B, Milatiner D, Block C, et al. Inconsistency of a model aimed at predicting bacteremia in hospitalized patients. J Clin Epidemiol.1993;46:1035-40.
24. Yehezkelli Y, Subah S, Elhanan G, et al. Two rules for early prediction of bacteremia: Testing in a university and a community hospital. J Gen Intern Med. 1996;11:98-103.
25. Bishara J, Golan-Cohen A, Robenshtok E, et al. Antibiotic use in patients with erysipelas: a retrospective study. Isr Med Assoc J. 2001;3:722-4.
26. Carratala J, Roson B, Fernandez-Sabe N, et al. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis. 2003;22:151-7.
27. Ginsberg MB. Cellulitis: analysis of 101 cases and review of the literature. South Med J. 1981;74:530-3.
28. Lutomski DM, Trott AT, Runyon JM, et al. Microbiology of adult cellulitis. J Fam Pract. 1988;26:45-8.
29. Newell PM, Norden CW. Value of needle aspiration in bacteriologic diagnosis of cellulitis in adults. J Clin Microbiol. 1988;26:401-4.
30. Sachs MK. The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults.[erratum appears in Arch Intern Med 1991 Feb;151(2):244]. Arch Intern Med. 1990;150:1907-12.